A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Institut Curie
Children's Hospital of Philadelphia
Institut Curie
Seattle Children's Hospital
Seattle Children's Hospital
St. Jude Children's Research Hospital
Phoenix Children's Hospital
St. Jude Children's Research Hospital
Medical College of Wisconsin
Eye & ENT Hospital of Fudan University
Washington University School of Medicine
Targeted Therapy Technologies, LLC
Eye & ENT Hospital of Fudan University
Fundació Sant Joan de Déu
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Seoul National University Hospital
Targeted Therapy Technologies, LLC
Duke University
Seoul National University Hospital
Sun Yat-sen University
Chengdu Kanghong Biotech Co., Ltd.
Sun Yat-sen University
Sun Yat-sen University
Barbara Ann Karmanos Cancer Institute
Children's Hospital Medical Center, Cincinnati
Ann & Robert H Lurie Children's Hospital of Chicago
Emory University
University of California, San Francisco
Emory University
St. Jude Children's Research Hospital
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Guangzhou Women and Children's Medical Center
The Hospital for Sick Children
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Stanford University
Wills Eye
Hadassah Medical Organization
Hospital Sant Joan de Deu
NYU Langone Health
Memorial Sloan Kettering Cancer Center
Hadassah Medical Organization
Laboratorio Elea Phoenix S.A.
National Cancer Institute (NCI)
Sun Yat-sen University
M.D. Anderson Cancer Center
Sun Yat-sen University